Advocacy intelligence hub — real-time data for patient organizations
Washington University School of Medicine — PHASE2
Natera, Inc. — NA
FutureGen Biopharmaceutical (Beijing) Co., Ltd — PHASE3
Astellas Pharma Global Development, Inc. — PHASE3
TME Pharma AG — PHASE2
Xerient Pharma — PHASE1, PHASE2
Alpha Tau Medical LTD. — NA
Insel Gruppe AG, University Hospital Bern — NA
RenJi Hospital
PanTher Therapeutics — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
BioNTech Responsible Person
BioNTech SE
Robert L Coleman
NRG Oncology
📍 Anchorage, Alaska
Thanh H Dellinger, MD, M.D
City of Hope Medical Center
📍 DUARTE, CA
Weijia Fang, M.D
Zhejiang University
Ankona Ghosh, MD, MD
Cedars-Sinai Medical Center
📍 LOS ANGELES, CA
Ying Yuan, M.D
Second Affiliated Hospital, School of Medicine, Zhejiang University